Idiopathic pulmonary fibrosis

Results: 134



#Item
1Genome Sequencing of Idiopathic Pulmonary Fibrosis in Conjunction with a Medical School Human Anatomy Course Akash Kumar1,2,3, Max Dougherty1,2,3., Gregory M. Findlay1,2,3., Madeleine Geisheker1,2., Jason Klein1,2,3., Jo

Genome Sequencing of Idiopathic Pulmonary Fibrosis in Conjunction with a Medical School Human Anatomy Course Akash Kumar1,2,3, Max Dougherty1,2,3., Gregory M. Findlay1,2,3., Madeleine Geisheker1,2., Jason Klein1,2,3., Jo

Add to Reading List

Source URL: krishna.gs.washington.edu

Language: English - Date: 2015-06-15 15:31:20
    2Reset Form  SPECIAL AUTHORIZATION REQUEST ESBRIET® (pirfenidone) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8

    Reset Form SPECIAL AUTHORIZATION REQUEST ESBRIET® (pirfenidone) Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8

    Add to Reading List

    Source URL: www.gov.pe.ca

    Language: English - Date: 2016-05-27 11:46:42
    3BMS_2016_Inflammation_emphysema_Fibrosis_2016.pdf

    BMS_2016_Inflammation_emphysema_Fibrosis_2016.pdf

    Add to Reading List

    Source URL: edit.cms.unibe.ch

    Language: English - Date: 2016-05-26 09:57:43
    4

    CITY OF PROCLAMATION WHEREAS, idiopathic pulmonary fibrosis (IPF) is a serious disorder that creates scarring (fibrosis) in the delicate lung tissue of affected patients causing progressive, incurable lung di

    Add to Reading List

    Source URL: www.globalpfawareness.org

    Language: English
      5SPECIAL AUTHORIZATION REQUEST FORM

      SPECIAL AUTHORIZATION REQUEST FORM

      Add to Reading List

      Source URL: www.health.gov.nl.ca

      Language: English - Date: 2015-07-10 08:31:24
      6IDIOPATHIC PULMONARY FIBROSIS (IPF) AFFECTS AS MANY ASCommon symptoms:3,4

      IDIOPATHIC PULMONARY FIBROSIS (IPF) AFFECTS AS MANY ASCommon symptoms:3,4

      Add to Reading List

      Source URL: www.boehringer-ingelheim.com

        7Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri

        Bristol-Myers Squibb Signs Exclusive Option Agreement to Acquire Galecto Biotech AB and its Novel Galectin-3 inhibitor in Development for Idiopathic Pulmonary Fibrosis (NEW YORK and COPENHAGEN – November 3, Bri

        Add to Reading List

        Source URL: sunstone.eu

        - Date: 2014-11-03 07:57:22
          8Uridine for treatment of COPD and pulmonary fibrosis Technology The nucleoside uridine, which does not carry any phosphate groups, is useful for the treatment or prevention of chronic obstructive pulmonary disease (COPD)

          Uridine for treatment of COPD and pulmonary fibrosis Technology The nucleoside uridine, which does not carry any phosphate groups, is useful for the treatment or prevention of chronic obstructive pulmonary disease (COPD)

          Add to Reading List

          Source URL: www.campus-technologies.de

          Language: English - Date: 2015-02-19 08:22:51
          9Structural and Functional Quantitative Imaging Techniques are Complimentary in Retrospective Analysis of PRM-151 Data in Idiopathic Pulmonary Fibrosis (IPF) B van den Blink, MD, PhD1; J Burggraaf, MD, PhD2; LD Morrison,

          Structural and Functional Quantitative Imaging Techniques are Complimentary in Retrospective Analysis of PRM-151 Data in Idiopathic Pulmonary Fibrosis (IPF) B van den Blink, MD, PhD1; J Burggraaf, MD, PhD2; LD Morrison,

          Add to Reading List

          Source URL: www.promedior.com

          Language: English - Date: 2014-09-21 12:39:58
          10New Therapy in Pulmonary Fibrosis CCR6 Mediates CCL18 Induced Fibrosis and EMT Technology CCL18 is a chemokine released by alternatively activated macrophages. We have recently documented that serum CCL18 concentrations

          New Therapy in Pulmonary Fibrosis CCR6 Mediates CCL18 Induced Fibrosis and EMT Technology CCL18 is a chemokine released by alternatively activated macrophages. We have recently documented that serum CCL18 concentrations

          Add to Reading List

          Source URL: www.campus-technologies.de

          Language: English - Date: 2015-02-19 08:11:00